Using co-immunoprecipitation (Co-IP) and mass spectrometry analyses (MS), we observed that ILF3 co-purified with HOXC8 and co-localized with HOXC8 in the nuclei of breast cancer cells. This evidence concerns the gene ILF3 and breast carcinoma.